Last Posted: Mar 06, 2020
- Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
T Fehlmann et al, JAMA Oncology, March 5, 2020 - Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer.
Xie Yang et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 25(1) 150-157 - Harmonization and Standardization of Panel-Based Tumor Mutational Burden (TMB) Measurement: Real-World Results and Recommendations of the QuIP Study.
Stenzinger Albrecht et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 Feb - Inherited lung cancer: a review.
de Alencar Viviane Teixeira Loiola et al. Ecancermedicalscience 2020 141008 - A CRISPR Test for Rapidly and Sensitively Detecting Circulating EGFR Mutations.
Tsou Jen-Hui et al. Diagnostics (Basel, Switzerland) 2020 Feb 10(2) - Brain Tumor Analysis Empowered with Deep Learning: A Review, Taxonomy, and Future Challenges.
Nadeem Muhammad Waqas et al. Brain sciences 2020 Feb 10(2) - Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
Lee Jang Hyuck et al. Annals of surgical oncology 2019 Oct 26(11) 3756-3764 - Blood test shows high accuracy in detecting stage I non-small cell lung cancer.
Goebel Cherylle et al. BMC cancer 2020 Feb 20(1) 137 - The impact of long-term PM 2.5 exposure on specific causes of death: exposure-response curves and effect modification among 53 million U.S. Medicare beneficiaries.
Wang Bingyu et al. Environmental health : a global access science source 2020 Feb 19(1) 20 - Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer.
Huang Di et al. Targeted oncology 2020 Feb
.png)
No hay comentarios:
Publicar un comentario